Status:
RECRUITING
The Research Value of Multi-omics and Multi-modal Information in the Diagnosis and Treatment of Urinary System Tumors
Lead Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions:
Urinary System Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Obtain puncture or surgically removed tumor tissue samples from patients with urinary tract tumors and perform RNA-sequencing, Single-cell RNA-sequence, Spatial Transcriptomics, Proteomics, and Intrat...
Eligibility Criteria
Inclusion
- Patients were treated for bladder cancer, kidney cancer, and prostate cancer in Wuhan Union Hospital from January 2024 to January 2026;
- Aged \> 18 years old;
- Urinalysis, urine exfoliated cells, ultrasound, CT, and MR examinations indicated the above tumors;
- Tissue biopsy pathological examination confirmed the diagnosis of the above tumors.
Exclusion
- Poor image quality;
- Incomplete clinical data or loss of follow-up;
- Presence of another primary malignant tumor other than urinary tract tumor;
- Unclear pathological diagnosis
Key Trial Info
Start Date :
November 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 20 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06490211
Start Date
November 20 2023
End Date
November 20 2026
Last Update
July 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Union Hospital，Tongji Medical College，Huazhong University of Science and Technology
Wuhan, Hubei, China, 430000